Status:
UNKNOWN
Telemedicine for Linkage to Care People Who Injected Drugs With Hepatitis C
Lead Sponsor:
University of La Laguna
Conditions:
Hepatitis C Virus Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators have designed a community-based intervention study to all subjects attended in drug addiction centers screened for hepatitis C virus (HCV) to evaluate the efficacy and acceptance of ...
Detailed Description
Our current programme of engagement to healthcare and HCV screening based on on-site dried blood spot (DBS) testing has shown to be successful, but with drop-outs in the HCV cascade of care due to eco...
Eligibility Criteria
Inclusion
- Subjects 18 years old or older with a valid sanitary card in our public health system
- Signed Informed consent
- Tested for HCV: a) no previous documented HCV antibody request or b) with a previous positive HCV antibody test without RNA result or positive result without treatment or confirmed sustained virological response or c) with a negative HCV antibody result tested more than one year ago
- No current surveillance by any hepatitis specialized care (hepatology or internal medicine)
Exclusion
- Previous DBS testing at DAC lost to follow-up
Key Trial Info
Start Date :
July 5 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
166 Patients enrolled
Trial Details
Trial ID
NCT04035980
Start Date
July 5 2019
End Date
December 31 2023
Last Update
May 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario de Canarias
San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain, 38320